These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040 [TBL] [Abstract][Full Text] [Related]
3. Activity of ceftolozane-tazobactam against a broad spectrum of recent clinical anaerobic isolates. Snydman DR; McDermott LA; Jacobus NV Antimicrob Agents Chemother; 2014; 58(2):1218-23. PubMed ID: 24277025 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983. Nord CE; Olsson-Liljequist B Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139 [TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes]. Dubreuil L; Houcke I; Singer E Pathol Biol (Paris); 1998 Feb; 46(2):147-52. PubMed ID: 9769928 [TBL] [Abstract][Full Text] [Related]
11. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria. Urbán E; Nagy E; Pál T; Sonnevend A; Conlon JM Int J Antimicrob Agents; 2007 Mar; 29(3):317-21. PubMed ID: 17196372 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms. Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV Antimicrob Agents Chemother; 2013 May; 57(5):2401-4. PubMed ID: 23459482 [TBL] [Abstract][Full Text] [Related]
13. Review of the in vitro activity of gemifloxacin against gram-positive and gram-negative anaerobic pathogens. Goldstein EJ J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():55-65. PubMed ID: 10824034 [TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates. Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700 [TBL] [Abstract][Full Text] [Related]
15. [Investigations into the occurrence and the antibiotic susceptibility of gram negative anaerobes of the genera Bacteroides, Prevotella, Porphyromonas and Fusobacterium in specimens obtained from diseased animals]. Even H; Rohde J; Verspohl J; Ryll M; Amtsberg G Berl Munch Tierarztl Wochenschr; 1998 Oct; 111(10):379-86. PubMed ID: 9818460 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds. Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibiotic susceptibility of Bacteroides, Prevotella and Fusobacterium species isolated from patients of the N. N. Blokhin Cancer Research Center, Moscow, Russia. Shilnikova II; Dmitrieva NV Anaerobe; 2015 Feb; 31():15-8. PubMed ID: 25157873 [TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens. Watt B; Naden MG Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Werner H; Heizmann WR; Höflsauer M Infection; 1991; 19(5):377-9. PubMed ID: 1800380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]